Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Oligoastrocytomas”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Study completedNCT00165360
What this trial is testing

Prolonged Daily Temozolomide for Low-Grade Glioma

Who this might be right for
GliomaAstrocytomaOligodendroglioma
Dana-Farber Cancer Institute 46
Early research (Phase 1)Study completedNCT02423525
What this trial is testing

Safety Study of Afatinib for Brain Cancer

Who this might be right for
Brain Cancer
Santosh Kesari 24
Testing effectiveness (Phase 2)Study completedNCT00362570
What this trial is testing

Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma

Who this might be right for
Oligoastrocytoma, MixedAnaplastic Oligodendroglioma
Ohio State University Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00033280
What this trial is testing

Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic Oligoastrocytomas

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 42
Early research (Phase 1)Study completedNCT00024557
What this trial is testing

Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 40
Testing effectiveness (Phase 2)Study completedNCT00667394
What this trial is testing

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT02372409
What this trial is testing

Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors

Who this might be right for
GliomaPilocytic AstrocytomaAnaplastic Astrocytoma+6 more
Washington University School of Medicine 6
Testing effectiveness (Phase 2)Study completedNCT00024570
What this trial is testing

Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more
INSYS Therapeutics Inc 60
Testing effectiveness (Phase 2)Study completedNCT00400816
What this trial is testing

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Who this might be right for
Central Nervous System TumorsBrain Tumor
The Cleveland Clinic 29
Testing effectiveness (Phase 2)Ended earlyNCT02023905
What this trial is testing

Everolimus With and Without Temozolomide in Adult Low Grade Glioma

Who this might be right for
Low Grade GliomaWorld Health Organization (WHO) Grade II AstrocytomasOligodendrogliomas+1 more
University of California, San Francisco 27
Testing effectiveness (Phase 2)Study completedNCT00049127
What this trial is testing

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

Who this might be right for
Adult Anaplastic OligodendrogliomaAdult Mixed GliomaAdult Oligodendroglioma+1 more
Alliance for Clinical Trials in Oncology 64
Early research (Phase 1)Study completedNCT00526812
What this trial is testing

A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas

Who this might be right for
Glioma
Biogen 54
Early research (Phase 1)Study completedNCT00734682
What this trial is testing

A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+1 more
University of California, San Francisco 34
Testing effectiveness (Phase 2)Ended earlyNCT00062504
What this trial is testing

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Teva Branded Pharmaceutical Products R&D, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00008008
What this trial is testing

Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Herbert Irving Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00041587
What this trial is testing

Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more
INSYS Therapeutics Inc 80
Testing effectiveness (Phase 2)Study completedNCT00003372
What this trial is testing

Topotecan in Treating Patients With Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
NCIC Clinical Trials Group 17
Testing effectiveness (Phase 2)Study completedNCT00995007
What this trial is testing

Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas

Who this might be right for
Glioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 112
Early research (Phase 1)Active Not RecruitingNCT03152318
What this trial is testing

The Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2

Who this might be right for
Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+11 more
Dana-Farber Cancer Institute 62
Early research (Phase 1)Study completedNCT00064779
What this trial is testing

Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+2 more
INSYS Therapeutics Inc 18
Next Page